Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhein Siegfried Sa De CvfiledCriticalRhein Siegfried Sa De Cv
Priority to UY0001035541ApriorityCriticalpatent/UY35541A/en
Publication of UY35541ApublicationCriticalpatent/UY35541A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a una composición farmacéutica oral que comprende una cantidad de ácidos grasos Omega-3, una cantidad de Hierro y una cantidad de Zinc junto a excipientes farmacéuticamente aceptables. La composición de la presente invención es utilizada en la fabricación de un medicamento que es empleado en el tratamiento del trastorno del déficit de atención e hiperactividad. Adicionalmente, la presente invención también se refiere a un proceso para preparar dicha composición farmacéutica oral que comprende mezclar los ácidos grasos Omega-3, Hierro y Zinc, junto a excipientes farmacéuticamente aceptables.The present invention relates to an oral pharmaceutical composition comprising an amount of Omega-3 fatty acids, an amount of Iron and an amount of Zinc together with pharmaceutically acceptable excipients. The composition of the present invention is used in the manufacture of a medicament that is employed in the treatment of attention deficit hyperactivity disorder. Additionally, the present invention also relates to a process for preparing said oral pharmaceutical composition comprising mixing Omega-3, Iron and Zinc fatty acids, together with pharmaceutically acceptable excipients.
UY0001035541A2014-04-222014-04-22
Composition of omega-3 fatty acids, zinc and iron for the treatment of attention deficit hyperactivity disorder (ADHD)
UY35541A
(en)
Use of r-2-4-2-ethoxy-3-4-trifluoromethylphenoxypropyl-thio-2-methylphenoxy acetic acid or a salt thereof in the manufacture of a medicament to treat a condition that is a non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.